Hematology

Trend of reduced therapy-related hematologic cancers among patients with three cancer types likely driven by immune modulation, Roswell Park team proposes

Purdue startup gets $2 million SBIR grant to fast-track cancer drug platform technology

Revive Therapeutics files a Pre-CTA meeting request with Health Canada for Bucillamine in the treatment of COVID-19

Global Preclinical Data Forum says sharing negative science results is key to neuroscience progress

Antibody therapeutic from Compugen demonstrates no dose-limiting toxicities

Multi-institution research team finds that cancer-driving mutations can arise in endometrial cells early in life

PTC Therapeutics enters into an agreement to acquire Censa Pharmaceuticals

Scholar Rock preclinical study shows SRK-181 can reverse immune cell exclusion

Regeneron and Zai Lab create regional strategic collaboration for REGN1979

Collaborators aim to accelerate development of novel cell therapies and aid both academia and industry

New compound may help reduce chronic opioid use and facilitate dose tapering

Induced pluripotent stem cells show success in treating hemophilia A in mice